semaglutide and alzheimer's does not slow the progression of disease Ozempic linked to lower Alzheimer's

The effect of L-carnitine supplementation on anthropometric and malnutrition status in acute ischemic stroke patients: a triple-blinded randomized clinical trial

Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-kappaB pathway in vitro

Novo Nordisk views cardiovascular diseases, chronic kidney diseases, and metabolic diseases, including type 2 diabetes, obesity, and metabolic dysfunction-associated steatohepatitis (MASH), as interrelated cardiometabolic conditions that often coexist in patients

It is described as a scientific breakthrough for weight loss when used correctly

Non-alcoholic fatty liver disease (NAFLD) does not itself make you urinate more

Understanding these pathways helps explain why Retatrutide has become a focus of obesity research